Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07389031 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Maralixibat for Intrahepatic Cholestasis of Pregnancy

Study acronym: METAPHOR
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An open label phase 2a/b trial of maralixibat in patients with Intrahepatic Cholestasis of Pregnancy (ICP) and elevated serum bile acid concentrations (sBA) to evaluate safety and tolerability
Trial Details
NCT Number NCT07389031
Lead Sponsor Imperial College London
Collaborators: Mirum Pharmaceuticals, Inc.
Conditions Intrahepatic Cholestasis of Pregnancy
Enrollment 28 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov